OneDigital Investment Advisors LLC Takes Position in Encompass Health Corporation (NYSE:EHC)

OneDigital Investment Advisors LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,596 shares of the company's stock, valued at approximately $263,000.

A number of other hedge funds have also recently made changes to their positions in the company. US Bancorp DE boosted its stake in shares of Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after purchasing an additional 121 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares in the last quarter. Arlington Trust Co LLC boosted its stake in shares of Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after purchasing an additional 125 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its stake in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Finally, Merit Financial Group LLC boosted its stake in shares of Encompass Health by 4.1% during the first quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock valued at $427,000 after purchasing an additional 166 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on EHC shares. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Barclays lifted their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Royal Bank Of Canada lifted their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Finally, KeyCorp lifted their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $131.50.

Insider Buying and Selling at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president owned 79,710 shares in the company, valued at $9,149,910.90. The trade was a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the sale, the chief executive officer owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,663 shares of company stock valued at $16,034,082. 2.00% of the stock is currently owned by company insiders.

Encompass Health Trading Up 0.9%

EHC traded up $1.01 during trading on Friday, hitting $118.50. The company's stock had a trading volume of 885,148 shares, compared to its average volume of 708,685. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.13. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. The stock's fifty day moving average price is $119.58 and its 200-day moving average price is $106.28. The firm has a market capitalization of $11.94 billion, a P/E ratio of 24.48, a PEG ratio of 2.41 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the firm earned $1.12 earnings per share. The company's revenue was up 10.6% compared to the same quarter last year. Analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.